The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Olive oil grower and producer Cobram Estate Olives (CBO) has completed its first full day of trading after listing on the ASX
  • The Australian business listed on the stock exchange on Wednesday, August 11, under the ticker code CBO
  • Cobram released a number of business updates ahead of its listing, including an explanation of its olive trees’ biennial fruit bearing cycles
  • COB argues its results should therefore be considered over a two-year period, as its profits are often recorded in a year of production and not sales
  • Shares in Cobram Estate Olives are trading up 5.65 per cent at $1.97 per share at 2:18 pm AEST in a $720.6 million market cap

Olive oil grower and producer Cobram Estate Olives (CBO) has completed its first full day of trading after listing on the ASX.

The Australian food business listed on the stock exchange on Wednesday, August 11, under the ticker code CBO.

Since listing, Cobram has released a number of business updates including an explanation of its olive trees’ biennial fruit bearing cycles.

Chair Rob McGavin said in a statement that its trees produced large volumes only every second year.

“Olive trees naturally bear fruit in biennial cycles, with a higher yielding crop one year typically followed by a lower yielding crop in the next year,” Mr McGavin said.

As a result, the Cobram Chair explained the company’s profits were often recorded in a year of production and not sales.

“Under the relevant accounting standards, the profit for each year of harvest is adjusted by the difference between the cost of production and the net realisable value of the oil produced in that year,” Mr McGavin said.

“This means that profit is recorded in the year of production, rather than the year of sale.”

CBO has opened its second day of trading on Thursday at $1.90 per share.

Share were up 5.91 per cent at $1.97 per share at 2:18 pm AEST at in a $720.6 million market cap.

CBO by the numbers
More From The Market Online

Cettire turbulent on $191M revenue, but no word on customs scandal

Cettire shares spiked upwards right out the gate on Friday on the same day the company…

Vitura joint venture prescribes shrooms for therapeutic use in Australian-first

In an Australian-first pharmaceutical achievement, Vitura Health Limited has announced the first ever shipment of 'shrooms'…

23% profit jump for NZ dairy co-op Fonterra

New Zealand dairy cooperative Fonterra has raised its profits 23 percent to NZ$674 million in the…

The Calmer Co’s FijiKava now at USA’s Walmart

Not long after hitting the shelves at Coles, Calmer Co's Fiji Kava products have hit the…